gold-investing Ascot Announces Closing of the First Tranche of Private Placement, Changes to Leadership and Creditor Restructuring
gold-investing Ascot Announces Pricing of C$150 Million Brokered Private Placement and Nebari Restructuring Terms
gold-investing Ascot to Launch C$0.01 Per Share Rights Offering and 50:1 Share Consolidation; Enters into Advisory Agreement with Fiore and Support of Major Shareholders and Creditors
FDA Accepts LEQEMBI® IQLIK Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
FDA Accepts LEQEMBI® IQLIKTM Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
CORRECTION - Domestic Metals Engages ICP Securities Inc. for Automated Market Making Services and provides further details on the engagement of Michael Pound
